Company intelligence / Profile preview

OmneDiem

Ann Arbor, Michigan, United States

Ownership: Private
Development stage: Other

Overview

OmneDiem is a commercial-stage dietary supplement company specializing in products for histamine intolerance and other underserved health concerns. The company launched its flagship Histamine Digest product line in 2016 and has since expanded to include cognitive support, joint health, and sports nutrition products.

Therapeutic areas: ImmunologyRheumatologyGastroenterologyNeurologyPsychiatry
Modalities: Enzyme supplementationDietary supplement
Industry: Food & Nutrition

Beyond the preview

Go deeper on OmneDiem.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OmneDiem.

Explore the full profile